Our News on Newswise

Houston Methodist Psychologist shares his advice on managing COVID19-related stress and anxiety

COVID-19 has caused social isolation, a disruption in routine and a fear in many that they will catch the virus. This type of sudden change can induce stress and anxiety. However, Houston Methodist psychologist, William Orme, Ph.D., says there are...
27-May-2020 10:55 AM EDT Add to Favorites

Newswise: BloodDonorCenter.jpg

Study finds COVID plasma therapy safe, with 76% patients improving

The first convalescent plasma transfusion trial results from Houston Methodist have been released. Of the 25 patients in the study, 19 have improved and 11 have been discharged. With no adverse side effects caused by the therapy, the study concluded...
13-May-2020 12:05 PM EDT Add to Favorites

Houston Methodist researchers find telling clues in virus genes from COVID-19 patients

Houston Methodist released gene sequencing results from the first strains of the virus causing COVID-19 disease in Houston. Results reveal multiple introductions of SARS-CoV-2 into Houston followed by rapid community spread. No evidence was found of...
8-May-2020 2:40 PM EDT Add to Favorites

Investigational therapy gaining reputation as promising antiviral drug to fight COVID-19

COVID-19 patients in a clinical trial at Houston Methodist Hospital are responding quickly to the antiviral drug Remdesivir. Sponsored by Gilead Sciences, Houston Methodist was the fifth site in the U.S. to join the trials and the only trial site in...
17-Apr-2020 6:05 PM EDT Add to Favorites

Newswise: Plasma_photo_DrSalazar.jpg

Houston Methodist Ramps up Plasma Therapy as FDA Approves Clinical Trial

The FDA’s announcement Friday to approve convalescent serum therapy as a large-scale clinical trial opened the door for more patients to receive the potentially life-saving gift of a donor’s plasma.
4-Apr-2020 1:40 PM EDT Add to Favorites

Newswise: April 2020 Science Advances-H. Shen-Image.jpg

Fatty acid in triglycerides proves an effective platform for biological drug delivery

Houston Methodist nanomedicine researchers are studying a new drug delivery system that transports oral medication via triglycerides that could eliminate the need for injections or IV treatments of some biologic drugs for rheumatoid arthritis and...
2-Apr-2020 8:30 AM EDT Add to Favorites

Newswise: BloodDonorCenter.jpg

FDA Approves First Plasma Therapy for Houston Methodist COVID-19 Patient

Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside...
30-Mar-2020 8:30 AM EDT Add to Favorites

Newswise: 2020MusserGroupAstrepimagecreditNIAID.jpg

Discovery reveals antibiotic-resistant strep throat may be too close for comfort

Infectious disease scientists identified strains of group A streptococcus that are less susceptible to commonly used antibiotics, a sign that the germ causing strep throat and flesh-eating disease may be moving closer to resistance to penicillin and...
27-Jan-2020 11:05 AM EST Add to Favorites

See All News

Our Experts on Newswise

Newswise: DrMassud-HMAC-SM.jpg

Research and innovation as an essential function amid the COVID-19 pandemic

Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has...
29-Apr-2020 12:10 PM EDT

Newswise: KashBita.jpg

Bita Kash, PhD, Researcher with Houston Methodist, available to discuss COVID-19 and African American communities

20-Apr-2020 2:30 PM EDT

Newswise: mcculloch09.2013photo5brown2.jpg

Orthopedic surgeon available to discuss pectoral injuries in professional athletes

8-Jan-2020 3:00 PM EST

Early and Unusual Flu Season a Risk for Persons Who Vape, Have Chronic Disease, More

10-Dec-2019 4:05 PM EST

How to avoid holiday headaches

Six tips for avoiding holiday headache triggers from Houston Methodist neurologist Bing Liao, M.D., M.Sc.
21-Nov-2019 12:05 PM EST

Embarrassing symptoms prevent relief of treatable conditions

Nearly 25% of women live with treatable conditions known as pelvic floor disorders, but there is one main reason why the vast majority of them will not seek treatment: they are too embarrassed to talk about it.
20-Nov-2019 11:20 AM EST

Three tips for better sleep

More than one-third of Americans get less than seven hours of sleep each night, putting them at risk for serious, chronic health conditions such as diabetes, heart disease and obesity. The real victim of a lack of sleep, however, is the brain.
29-Oct-2019 2:15 PM EDT

Five facts your OB-GYN wants you to know about IUDs

Intrauterine devices, or IUDs, are a great birth control option, but many women choose other forms of birth control because they have reservations about IUDs. A Houston Methodist OB-GYN answered common questions patients ask her about this very...
2-Oct-2019 2:05 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.


About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.



Stefanie Asin
Public Relations Director
Corporate Communications



Gale Smith
Public Relations Manager
Research Institute, Gastroenterology & GI Surgery, Ophthalmology, Otolaryngology/ENT



George Kovacik
Public Relations Manager
Heart Center, Transplant Center, Endocrinology, General Surgery, Plastic Surgery, Emergency Medicine



Hannah Pietsch
Senior Media Relations Coordinator
Neurological Institute, Women’s Health (OB/GYN)



Lisa Merkl
Medical Research Editor, PR Office
Research Institute



Ashley White
Senior Media Relations Specialist
Cancer Center, Orthopedics & Sports Medicine